SEC Form 4 · accession 0001652252-15-000067
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giovanni Magni
Officer — EVP, Chief Strategy Officer
Period of report
Nov 18, 2015
Accepted (ET)
Nov 20, 2015 · 1:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Nov 18, 2015 | M | 6,000 | $62.47 | A | 18,655 | D | |
| Bio-Rad A Common Stock | Nov 18, 2015 | S | 6,000 | $140.00 | D | 12,655 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $62.47 | Nov 18, 2015 | M | 6,000 | D | — | Apr 3, 2016 | Bio-Rad A Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1The option vested in five equal annual installments beginning on April 3, 2007.